The European Academy of Dermatology and Venereology (EADV) was founded in 1987 and has over 9,000...

A summary of highlights from the EADV Congress 2025, which was held at the Paris Expo...

The current standard treatment for light chain amyloidosis (AL) is chemotherapy. While often effective, it can...

The European Alliance of Associations for Rheumatology (EULAR) – the European umbrella organisation representing scientific societies...

The European Alliance of Associations for Rheumatology (EULAR), in partnership with the Paediatric Rheumatology European Society...

While there has been progress in the development of treatment for hepatocellular carcinoma (HCC) over the...

The European Society for Medical Oncology (ESMO) Congress 2024, which took place from 13-17 September in...

The health of the thymus is associated with cancer patients’ outcomes to immune checkpoint inhibitor treatment...

New data presented at ESMO 2025 suggests antibody-drug conjugates (ADCs) dramatically improve outcomes for patients with...

Erectile dysfunction (ED), the inability to achieve or maintain an erection for satisfactory sexual performance, affects...

The CD3×CD20 bispecific antibody (bsAb), epcoritamab, is approved as monotherapy for R/R diffuse large Bcell lymphoma...

Eosinophilic oesophagitis (EoE) is a chronic, inflammatory, immune- or antigen-mediated oesophageal disease, resulting from recruitment...